Reading some of hottods stuff and comparing pyc to neuren, the consensus was that pyc is about 18 months behind Neu in terms of the trials and hence also the share price. There are many differences though, an important one being we own 100% of all our drugs at present. But neuren has gone from approx a dollar to 20 in that time, so, if night follows day, over the next 18 months ( although this was 6 months ago) our sp will move up significantly. Any sign of efficacy will change the sp the most, and that could be later this year as there are a few now with this drug in them for 6 or so months. first step is the tox results out this week or next from what I’ve seen. That might trigger a deal on our second drug which would put more cash in the coffers and get us even further down the PKD path…
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)